To date, the mechanisms underlying the potential protective role of CRP and leptin-to-adiponectin ratio (a suggested surrogate marker of insulin resistance [39]) in breast carcinogenesis among premenopausal women are unclear and should be explored in experimental studies. The gene discussed is LEP; the disease is Insulin resistance.